ArticleCancer research communications2025

Safety and Efficacy of a Selective Inhibitor of Cyclin-dependent Kinase 9 (KB-0742) in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma.

Glenn J Hanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.